These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4895434)

  • 41. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
    Orö L
    Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953
    [No Abstract]   [Full Text] [Related]  

  • 42. [Arteriosclerosis--nicotinic acid therapy. 9. Treatment of hypercholesteremia].
    Selvaag O
    Lakartidningen; 1971 Apr; 68(15):1768. PubMed ID: 5577251
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thermoregulatory and hemodynamic aspects of acute drug-induced vasodilation in the skin and the simultaneous use of beta-blockers in arterial hypertension].
    Kaderávek F
    Vnitr Lek; 1981 Apr; 27(4):372-9. PubMed ID: 6117148
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of lipid nanocarriers on the performance of topical vehicles in vivo.
    Moddaresi M; Tamburic S; Williams S; Jones SA; Zhao Y; Brown MB
    J Cosmet Dermatol; 2009 Jun; 8(2):136-43. PubMed ID: 19527338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 46. [Meso-inositol hexa-nicotinate (Hexanicit) and pentaerythritol tetranicotinate (Bufon) for restless legs. A controlled blind study].
    Christiansen I
    Ugeskr Laeger; 1970 Aug; 132(32):1475-6. PubMed ID: 4917675
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on the effect of nicotinic acid and adenosine monophosphate on skin and muscle circulation in healthy subjects and patients with peripheral circulatory disorders].
    Gottstein U; Felix R; Flad HD; Sedlmeyer I
    Z Kreislaufforsch; 1966 Oct; 55(10):970-87. PubMed ID: 5994974
    [No Abstract]   [Full Text] [Related]  

  • 48. In-vitro and in-vivo evaluation of oligoethylene esters as dermal prodrugs of 18beta-glycyrrhetic acid.
    Puglia C; Ostacolo C; Sacchi A; Laneri S; Bonina F
    J Pharm Pharmacol; 2006 Mar; 58(3):311-9. PubMed ID: 16536897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes in psychic performance due to a drug which influences the brain metabolism].
    Amthauer R
    Wien Klin Wochenschr; 1971 Sep; 83(37):659-63. PubMed ID: 4939104
    [No Abstract]   [Full Text] [Related]  

  • 50. Potential hypolipidemic agents. I. Syntheses of esters related to 5-fluoro- and 5-chloronicotinic acid and the corresponding alcohols. Effects on noradrenaline-stimulated free fatty acid mobilization.
    Carlson LA; Hedbom C; Helgstrand E; Misiorny A; Sjöberg B; Stjernström NE; Westin G
    Acta Pharm Suec; 1972 Jun; 9(3):221-8. PubMed ID: 5053672
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical and experimental studies on fibrinolysis activation].
    Bielawiec M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1967; 15():1-92. PubMed ID: 4953138
    [No Abstract]   [Full Text] [Related]  

  • 52. [1st experiences with a new topical therapeutic agent].
    Beck W
    Med Welt; 1972 Sep; 23(36):1230-1. PubMed ID: 4562538
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of a nicotinic acid derivative on the radiation induced mitosis inhibition of Ehrlic ascites tumor cells].
    Kaufmann H; Piaszek L; Tiemann W; Bartholomä HJ
    Arzneimittelforschung; 1968 Dec; 18(12):1579-82. PubMed ID: 5756256
    [No Abstract]   [Full Text] [Related]  

  • 54. [Postgraduate medical education].
    Hebler MF
    Med Welt; 1972 Sep; 23(36):1232-3. PubMed ID: 4562539
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
    Hammerl H; Kränzl C; Pichler ; Studlar M
    Munch Med Wochenschr; 1969 Sep; 111(38):1912-6. PubMed ID: 5394857
    [No Abstract]   [Full Text] [Related]  

  • 56. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heat exchange mechanisms in moderate superficial hyperthermia].
    Respighi E; Toso A; Morgutti L
    Minerva Anestesiol; 1967 Apr; 33(4):329-40. PubMed ID: 5613778
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical and histologic aspects of trafuril test in children with rheumatic fever].
    Urban J; Miturska M
    Pol Tyg Lek; 1970 Apr; 25(16):569-72. PubMed ID: 5422163
    [No Abstract]   [Full Text] [Related]  

  • 59. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 60. Transfer of the experimental methodology described in the FDA guidance for corticosteroid bioequivalence testing to pharmacodynamic effects caused by nicotinates.
    Remane Y; Leopold CS
    J Cosmet Dermatol; 2006 Dec; 5(4):289-93. PubMed ID: 17716246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.